Norris Medicines has informed that a meeting of Board of Directors of the Company will be held on Saturday, 26th May, 2018, to consider and approve Audited Financial Results of the Company for the financial year ended 31st March, 2018. Further, the trading window shall remain closed from 15th May, 2018 to 29th May, 2018.
The above information is a part of company’s filings submitted to BSE.